P-233: SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer
hemotherapy followed by consolidation chemoradiotherapy (CRT) is a treatment option for locally advanced non-metastatic pancreatic cancer (LAPC), but outcome remains poor. The SCALOP trial identified a feasible, safe, and effective CRT regimen for LAPC: capecitabine (830mg/m2 oral bd) as radiosensit...
Disgrifiad llawn
Manylion Llyfryddiaeth
| Prif Awduron: |
Virdee, P,
Shaw, R,
Strauss, V,
Hamill, C,
Hurt, C,
Gwynne, S,
Corrie, P,
Bridgewater, J,
Parsons, P,
Tranter, B,
Sebag-Montefiore, D,
Chu, K,
Radhakrishna, G,
Hawkins, M,
O'Neill, E,
Campbell, S,
Love, S,
Maughan, T,
Mukherjee, S |
|---|
| Fformat: | Conference item
|
|---|
| Cyhoeddwyd: |
Oxford University Press
2017
|
|---|